Selections of our peer-reviewed research and commentary in the healthcare and mainstream press.
HealthIT Analytics followed up on a commentary published this month in Evidence-Based Oncology (EBO), the multistakeholder publication of The American Journal of Managed Care focused on cancer care delivery. Jennifer Bresnick covered the piece on CancerLinQ by its medical director, Robert S. Miller, MD, FACP, FASCO, of the American Society of Clinical Oncology, noting it is one of several attempts to bring Big Data analytics to clinicians at the point of care. Miller’s commentary is part of the EBO special June issue on quality measures, which are becoming an important feature of care delivery for payers. For the full commentary, click here.
A 2015 study in The American Journal of Managed Care (AJMC) that calculated the value of lost time to see the doctor—which averaged $43 per visit—was cited in a recent article from Rush University Medical Center on the potential of telemedicine for easing the lives of patients with Parkinson’s disease, and that of their caregivers. The original AJMC study put a number behind what so many patients already know—the time spent driving to the doctor or sitting in the waiting room has as much value (even more, it turns out), than the cost of a co-payment. Rush University noted that in Parkinson’s care, this opportunity costs doubles because a caregiver typically must take time from work to accompany the patient. Right now, Rush is absorbing the telemedicine costs during a pilot study. The 2015 study by Kristin N. Ray, MD, MS, et al, can be found here.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More